News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With Johnson & Johnson (JNJ) Deals, Berkeley's Aduro Biotech Gets New Chance To Prove Worth


6/18/2014 7:59:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The idea behind Aduro BioTech’s experimental cancer treatment—turning a dangerous food-borne bacterium into a Trojan horse against tumors—may seem startlingly new. But the project arose a dozen years ago, and incubated slowly in three different companies, before emerging this summer into a long-awaited splash of sunlight.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Xconomy

comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES